International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
Consensus recommendations
Education
Mental health
Neurodevelopmental disability
Rare genetic disorders
TAND
Tuberous sclerosis complex
Journal
Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832
Informations de publication
Date de publication:
14 09 2023
14 09 2023
Historique:
received:
27
04
2023
accepted:
28
08
2023
medline:
18
9
2023
pubmed:
15
9
2023
entrez:
14
9
2023
Statut:
epublish
Résumé
Tuberous sclerosis complex (TSC) is associated with a wide range of physical manifestations for which international clinical recommendations for diagnosis and management have been established. TSC is, however, also associated with a wide range of TSC-Associated Neuropsychiatric Disorders (TAND) that are typically under-identified and under-treated yet associated with a profound burden of disease. The contemporary evidence base for the identification and treatment of TAND is much more limited and, to date, consensus recommendations for the diagnosis and management of TAND have also been limited and non-specific. The TANDem project was launched with an international, interdisciplinary, and participatory consortium of 24 individuals, including TSC family representatives, from all World Health Organization (WHO) regions but one. One of the aims of the TANDem project was to generate consensus recommendations for the identification and treatment of TAND. At the time of this project, no internationally adopted standard methodology and methodological checklists existed for the generation of clinical practice recommendations. We therefore developed our own systematic procedure for evidence review and consensus-building to generate evidence-informed consensus recommendations of relevance to the global TSC community. At the heart of the consensus recommendations are ten core principles surrounded by cluster-specific recommendations for each of the seven natural TAND clusters identified in the literature (autism-like, dysregulated behavior, eat/sleep, mood/anxiety, neuropsychological, overactive/impulsive, and scholastic) and a set of wraparound psychosocial cluster recommendations. The overarching recommendation is to "screen" for TAND at least annually, to "act" using appropriate next steps for evaluation and treatment, and to "repeat" the process to ensure early identification and early intervention with the most appropriate biological, psychological, and social evidence-informed approaches to support individuals with TSC and their families. The consensus recommendations should provide a systematic framework to approach the identification and treatment of TAND for health, educational, social care teams and families who live with TSC. To ensure global dissemination and implementation of these recommendations, partnerships with the international TSC community will be important. One of these steps will include the generation of a "TAND toolkit" of "what to seek" and "what to do" when difficulties are identified in TAND clusters.
Sections du résumé
BACKGROUND
Tuberous sclerosis complex (TSC) is associated with a wide range of physical manifestations for which international clinical recommendations for diagnosis and management have been established. TSC is, however, also associated with a wide range of TSC-Associated Neuropsychiatric Disorders (TAND) that are typically under-identified and under-treated yet associated with a profound burden of disease. The contemporary evidence base for the identification and treatment of TAND is much more limited and, to date, consensus recommendations for the diagnosis and management of TAND have also been limited and non-specific.
METHODS
The TANDem project was launched with an international, interdisciplinary, and participatory consortium of 24 individuals, including TSC family representatives, from all World Health Organization (WHO) regions but one. One of the aims of the TANDem project was to generate consensus recommendations for the identification and treatment of TAND. At the time of this project, no internationally adopted standard methodology and methodological checklists existed for the generation of clinical practice recommendations. We therefore developed our own systematic procedure for evidence review and consensus-building to generate evidence-informed consensus recommendations of relevance to the global TSC community.
RESULTS
At the heart of the consensus recommendations are ten core principles surrounded by cluster-specific recommendations for each of the seven natural TAND clusters identified in the literature (autism-like, dysregulated behavior, eat/sleep, mood/anxiety, neuropsychological, overactive/impulsive, and scholastic) and a set of wraparound psychosocial cluster recommendations. The overarching recommendation is to "screen" for TAND at least annually, to "act" using appropriate next steps for evaluation and treatment, and to "repeat" the process to ensure early identification and early intervention with the most appropriate biological, psychological, and social evidence-informed approaches to support individuals with TSC and their families.
CONCLUSIONS
The consensus recommendations should provide a systematic framework to approach the identification and treatment of TAND for health, educational, social care teams and families who live with TSC. To ensure global dissemination and implementation of these recommendations, partnerships with the international TSC community will be important. One of these steps will include the generation of a "TAND toolkit" of "what to seek" and "what to do" when difficulties are identified in TAND clusters.
Identifiants
pubmed: 37710171
doi: 10.1186/s11689-023-09500-1
pii: 10.1186/s11689-023-09500-1
pmc: PMC10503032
doi:
Types de publication
Consensus Development Conference
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
32Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Behav Genet. 2011 May;41(3):437-44
pubmed: 21191642
Pediatr Neurol. 2015 Jan;52(1):16-24
pubmed: 25499093
Lancet Neurol. 2015 Jul;14(7):733-45
pubmed: 26067126
J Neurodev Disord. 2020 Sep 1;12(1):24
pubmed: 32873244
Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):309-320
pubmed: 30117265
Pediatr Neurol. 2021 Oct;123:50-66
pubmed: 34399110
Lancet. 2012 Apr 28;379(9826):1621-9
pubmed: 22377290
J Child Neurol. 1999 Jun;14(6):401-7
pubmed: 10385849
Front Neurol. 2020 Jul 07;11:603
pubmed: 32733359
Cochrane Database Syst Rev. 2022 Jul 13;7:CD013136
pubmed: 35844168
Pediatr Neurol. 2023 Oct;147:101-123
pubmed: 37598571
Orphanet J Rare Dis. 2017 Jan 5;12(1):2
pubmed: 28057044
Orphanet J Rare Dis. 2021 Oct 24;16(1):447
pubmed: 34689816
Pediatrics. 2019 Oct;144(4):
pubmed: 31570648
Epilepsy Behav. 2018 Jun;83:13-21
pubmed: 29631156
Am J Med Genet A. 2009 Mar;149A(3):387-95
pubmed: 19215038
Epilepsy Behav. 2011 Jan;20(1):68-74
pubmed: 21130696
J Intellect Disabil Res. 2018 Dec;62(12):1058-1071
pubmed: 29417652
Sci Rep. 2019 Nov 4;9(1):15908
pubmed: 31685858
Pediatr Neurol. 2018 Apr;81:38-44
pubmed: 29530301
Ann Neurol. 2021 Dec;90(6):874-886
pubmed: 34668231
JMIR Med Inform. 2018 May 31;6(2):e37
pubmed: 29853438
J Neurodev Disord. 2021 Dec 13;13(1):60
pubmed: 34903167
Curr Med Res Opin. 2011 Aug;27(8):1571-83
pubmed: 21692602
J Neurodev Disord. 2014;6(1):10
pubmed: 24822087
Orphanet J Rare Dis. 2018 Sep 10;13(1):157
pubmed: 30201051
Lancet. 2012 Sep 8;380(9845):899-907
pubmed: 22795511
Front Neurol. 2020 Aug 28;11:904
pubmed: 32982929
Epilepsy Behav. 2020 Feb;103(Pt A):106844
pubmed: 31864941
Lancet. 2022 Jan 15;399(10321):271-334
pubmed: 34883054
Curr Opin Psychiatry. 2016 Mar;29(2):103-25
pubmed: 26779860
J Child Neurol. 1998 Dec;13(12):624-8
pubmed: 9881533
Pediatr Neurol. 2015 Jan;52(1):25-35
pubmed: 25532776
Eur J Paediatr Neurol. 2019 Nov;23(6):801-807
pubmed: 31543331
BMJ Open. 2013 Dec 06;3(12):e003707
pubmed: 24319280
Front Psychiatry. 2022 Feb 28;13:834628
pubmed: 35295772
Pediatr Neurol. 2015 Apr;52(4):435-41
pubmed: 25771998
Neurology. 2019 Jul 9;93(2):e200-e209
pubmed: 31217257
Ann Clin Psychiatry. 2013 Nov;25(4):243-9
pubmed: 23926580
Epilepsy Behav. 2018 Oct;87:69-77
pubmed: 30173019
J Autism Dev Disord. 2015 Aug;45(8):2411-28
pubmed: 25737021
Res Integr Peer Rev. 2022 Jun 7;7(1):3
pubmed: 35672782
J Neurodev Disord. 2022 Feb 13;14(1):13
pubmed: 35151277
Eur Child Adolesc Psychiatry. 2005 Jul;14(4):183-90
pubmed: 15981129
Nat Rev Dis Primers. 2016 May 26;2:16035
pubmed: 27226234
Trials. 2016 Aug 11;17:398
pubmed: 27515417
Orphanet J Rare Dis. 2014 Nov 26;9:182
pubmed: 25424195
Ann Clin Transl Neurol. 2017 Nov 12;4(12):877-887
pubmed: 29296616
Cochrane Database Syst Rev. 2023 Feb 6;2:CD003406
pubmed: 36745863
Pediatr Neurol. 2013 Oct;49(4):255-65
pubmed: 24053983
Res Dev Disabil. 2017 May;64:119-130
pubmed: 28411579
Dev Med Child Neurol. 2013 Feb;55(2):146-153
pubmed: 23205844
JAMA. 2019 Aug 27;322(8):725-726
pubmed: 31322650
Epilepsy Behav. 2012 Jan;23(1):10-5
pubmed: 22099526